GTC Biotherapeutics (fka GTCB)

[poorgradstudent]

> when the PPS fell thirty cents after the dilution his paper loses were over 300,000$ a very percetage of his yearly salary,,,,think he liked that<

Well, considering his guaranteed take-home salary isn't a function of the share price, I don't think the paper losses on his stack of options causes him insomnia.

I think it is rare for the management of a start-up biotech to have their remuneration strongly tied to the stock price. Most get paid handsomely regardless of stock performance, and GTCB doesn't appear to be an exception.